Cargando…
Endothelial Dysfunction in Patients with Advanced Heart Failure Treated with Levosimendan Periodic Infusion Compared with Optimal Medical Therapy: A Pilot Study
Endothelial dysfunction (ED) is frequently found in patients with heart failure (HF). Among several pharmacological agents reported to improve endothelial function, levosimendan seems to be a promising one, even though, to date, only two previously published studies have evaluated its effects on ED...
Autores principales: | Maloberti, Alessandro, Sun, Jinwei, Zannoni, Jessica, Occhi, Lucia, Bassi, Ilaria, Fabbri, Saverio, Colombo, Valentina, Gualini, Elena, Algeri, Michela, Varrenti, Marisa, Masciocco, Gabriella, Perna, Enrico, Oliva, Fabrizio, Cipriani, Manlio, Frigerio, Maria, Giannattasio, Cristina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9501966/ https://www.ncbi.nlm.nih.gov/pubmed/36143358 http://dx.doi.org/10.3390/life12091322 |
Ejemplares similares
-
Lipoprotein(a): Cardiovascular Disease, Aortic Stenosis and New Therapeutic Option
por: Maloberti, Alessandro, et al.
Publicado: (2022) -
Haemodynamic effects of sacubitril/valsartan in advanced heart failure
por: Gentile, Piero, et al.
Publicado: (2022) -
Antithrombotic therapy in ventricular assist device (VAD) management: From ancient beliefs to updated evidence. A narrative review()
por: Morici, Nuccia, et al.
Publicado: (2018) -
COVID-19 and cardiovascular system: Not only heart but also vascular. The effects of the infection on arterial stiffness
por: Maloberti, A., et al.
Publicado: (2022) -
Continuous flow left ventricular assist devices do not worsen endothelial function in subjects with chronic heart failure: a pilot study
por: Cortese, Francesca, et al.
Publicado: (2021)